Health Care · Industrial Organic Chemicals

GEVO Gevo, Inc. SEC Filings & Insider Trading Activity 2026

company
CIK 1392380130 filings
Russell 2000

GEVO at a glance

Gevo, Inc. (GEVO, SEC CIK 1392380) filed its latest 10-K annual report on March 5, 2026, a 10-Q quarterly report on November 10, 2026, an 8-K current report on November 19, 2026 and Form 4 insider filings as recently as November 18, 2026. SignalX summarizes each filing with AI and tracks the company's insider trades and institutional holders.

  • For the fiscal year ended December 31, 2025 (FY2025), Gevo, Inc. (GEVO) reported revenue of $160.6 million (up 849.3% from FY2024) and a net loss of $33.8 million. Diluted EPS was -$0.14.
  • As of September 30, 2026, 27 institutional investment managers tracked by SignalX reported holding Gevo, Inc. (GEVO) shares worth $78.8 million in 13F-HR filings.
  • The most recent insider open-market sale reported on Form 4 was by Bowron Kimberly T on September 3, 2026 of 1,221 shares at $1.71 per share.
  • In the last 90 days, GEVO insiders reported 0 open-market purchases ($0) and 3 open-market sales ($10K) on Form 4, a net sale of $10K.

Source: SEC EDGAR (XBRL financial data, 13F-HR and Form 4 filings).

Revenue · FY2025
$160.6M
+849.3% vs prior year
Insiders · 90 days
0 buys · 3 sells
Net −$10K
13F holders
27 funds
$78.8M · +2 vs prior quarter
Latest 8-K
Nov 19, 2026
Item 7.01

AI 10-Q Quarterly Report Analysis

Latest 10-Q, quarter ended Sep 30, 2026

Risk Factors

  • No material changes to 2025 Annual Report risk factors
  • Unknown or currently immaterial risks could materially adversely affect results
  • Carried-forward risks include potential effects on business, financial condition and cash flows

Management Discussion & Analysis

  • Quarterly revenue $83.0M, up $40.2M YoY, driven by GevoND revenue of $77.5M vs $38.2M
  • Net income $25.1M vs $7.6M loss YoY, operating margin 36.4% vs (8.6)%
  • Best segment GevoND: $77.5M revenue, up $39.2M YoY, including $29.4M CFR credit revenue
  • Worst segment RNG production: 91,729 MMBtu vs 92,396 YoY, LCFS generation down 7% to 33,889
  • Cash $67.6M, operating cash flow $12.0M vs $(33.4)M YoY, capital investments $51.6M through nine months

AI summary of the GEVO 10-Q filed . Generated from the filing text; verify against the original.View on SEC EDGAR10-K vs 10-Q vs 8-K

AI 8-K Current Report Analysis

The most recent material events, by 8-K item

Filed Nov 19, 2026Full analysis →

Item 7.01: Regulation FD Disclosure

  • Renewable natural gas business update, including revised carbon intensity score
  • Updated financial outlook covering 2026 and 2027

Item EX-99.1: Item EX-99.1

  • Third-party validation supports improved RNG carbon intensity recognition under the updated 45ZCF-GREET model
  • RNG economics expected to increase approximately $15 million annually, up from more than $10 million previously estimated
Filed Nov 10, 2026Full analysis →

Item 2.02: Results of Operations and Financial Condition

  • Q3 2026 financial results announced for quarter ended September 30, 2026
  • Exhibit 99.1 contains the press release with Gevo’s detailed results

Item EX-99.1: Item EX-99.1

  • Record Q3 revenue $83 million, gross profit $48 million and net income $23 million, versus $43 million revenue and $8 million loss last year
  • Adjusted EBITDA $44 million, up from $7 million, with operating cash flow $41 million and quarter-end cash $68 million
Filed Oct 28, 2026Full analysis →

Item 5.02: Departure/Appointment of Directors or Principal Officers

  • K’Lynne Johnson appointed Class II independent director, term running through 2027 annual meeting
  • Annual compensation: $85,000 cash retainer plus $63,000 equity grant

Item EX-99.1: Item EX-99.1

  • K’Lynne Johnson appointed to Gevo’s board, effective November 4, 2026
  • Brings sustainable-technology, commercialization, manufacturing, and transformation expertise relevant to Gevo’s low-carbon fuels strategy

Item 7.01: Regulation FD Disclosure

  • Press release announces Ms. Johnson’s appointment to Gevo’s Board
  • Board addition may affect governance, oversight and strategic direction

AI summaries of GEVO 8-K current reports filed with the SEC. What 8-K item codes mean

SignalX for GEVO

Don't miss the next GEVO filing

  • Alerts as it files. A push when GEVO files an 8-K or an insider trades.
  • Fund moves. Which tracked funds opened, added or cut GEVO, by share count.
  • Ask anything. An AI agent that reads every GEVO filing and answers with sources.

GEVO alerts on your phone. Follow it in the SignalX Android app.

Get it on Google Play

Recent Insider Transactions (Form 4)

Latest reported trades by officers, directors and 10% owners

InsiderTypeDatePrice
Johnson KLynneANov 4, 2026-
Bowron Kimberly TSellSep 3, 2026$1.71
Bloom Paul DSellSep 3, 2026$1.71
Gruber Patrick R.SellSep 3, 2026$1.70
Barber James JBuyAug 21, 2026$1.54
Kettner David MichaelBuyAug 21, 2026$1.55
Werpy Todd AllenAAug 20, 2026-
Bloom Paul DMAug 13, 2026$1.18

Financial Summary
XBRL

Annual financial summary from SEC XBRL data
MetricFY2023FY2024FY2025
Profitability
Revenue-$16.9M$160.6M
Operating Income--$90.8M-$20.2M
Net Income-$66.2M-$78.6M-$33.8M
Op. Margin--536.9%-12.6%
Net Margin--464.9%-21.1%
Balance Sheet
Total Assets-$583.9M$718.9M
Equity$557.4M$489.5M$466.3M
ROE-11.9%-16.1%-7.3%
Per Share
EPS$-0.28$-0.34$-0.14
Cash Flow
Operating CF--$57.4M-$13.4M
CapEx$54.5M$51.1M$30.1M

Source: XBRL data in Gevo, Inc. (GEVO)'s 10-K filings on SEC EDGAR, in USD. Compare across companies →

13F Fund Holdings: Quarterly Trend

Latest: Q3 2026

Aggregate GEVO share value held by 13F filers tracked by SignalX, by quarter.

Quarterly totals table
GEVO shares held by 13F filers tracked by SignalX, by quarter
QuarterFundsTotal value
Q3 202627$78.8M
Q2 202625$94.2M
Q1 202625$163.4M
Q4 202525$116.0M
Q3 202525$104.2M
Q2 202523$61.7M
Q1 202519$32.2M
Q4 202416$55.9M
Position changes: Q2 2026 → Q3 2026
Top Buyers
Top Sellers
Closed Positions

Source: 13F-HR filings on SEC EDGAR (aggregated from 185 fund-quarter rows). Reflects only 13F filers tracked by SignalX, not the full institutional ownership universe. How 13F filings work

GEVO filing archive

AI analysis pages for each 10-K, 10-Q and 8-K

Latest 2026 SEC Filings: 10-K, 10-Q, 8-K & Form 4

FormFiling dateAnalysisSEC
8-KNov 19, 2026Analysis-
4Nov 18, 2026--
10-QNov 10, 2026Analysis
8-KNov 10, 2026Analysis-
8-KOct 28, 2026Analysis-
4Sep 4, 2026--
4Sep 4, 2026--
4Sep 4, 2026--
8-KAug 26, 2026Analysis-
4Aug 24, 2026--
4Aug 24, 2026--
4Aug 24, 2026--
4Aug 13, 2026--
4Aug 7, 2026--
4Aug 7, 2026--
SC 13GAug 7, 2026-
4Aug 7, 2026--
4Aug 7, 2026--
8-KAug 6, 2026Analysis-
10-QAug 6, 2026Analysis
8-KJul 16, 2026Analysis-
8-KJul 15, 2026Analysis-
4Jun 15, 2026--
4Jun 15, 2026--
4Jun 15, 2026--

Related Health Care companies

All Health Care →

GEVO SEC filings: frequently asked questions

Are GEVO insiders buying or selling?

In the last 90 days, Gevo, Inc. (GEVO) officers, directors and 10% owners reported no open-market purchases and 3 open-market sales worth $10,348 by 3 insiders on Form 4. Many insider sales are pre-planned or for taxes, so purchases usually carry more information.

Which institutions hold GEVO stock?

As of September 30, 2026, the largest Gevo, Inc. (GEVO) holders among the 13F filers tracked by SignalX were BlackRock ($24.2 million), State Street Corp ($13.7 million), Vanguard Capital Management LLC ($13.2 million), Vanguard Portfolio Management LLC ($6.5 million), Invesco Ltd ($5.0 million). 13F-HR reports are filed up to 45 days after each quarter ends.

What was GEVO's revenue in fiscal year 2025?

For the fiscal year ended December 31, 2025 (FY2025), Gevo, Inc. (GEVO) reported revenue of $160.6 million (up 849.3% from FY2024) and a net loss of $33.8 million. Diluted EPS was -$0.14. The figures come from the XBRL data in the 10-K.

What did GEVO report in its latest 8-K?

Gevo, Inc. (GEVO) filed an 8-K on November 19, 2026 reporting Item 7.01 (Regulation FD Disclosure). Renewable natural gas business update, including revised carbon intensity score.

What are the latest GEVO SEC filings?

Gevo, Inc. (GEVO) filed its latest 10-K annual report on March 5, 2026, a 10-Q quarterly report on November 10, 2026, an 8-K current report on November 19, 2026 and a Form 4 insider filing on November 18, 2026.

What is GEVO's SEC CIK number?

Gevo, Inc. (GEVO)'s SEC Central Index Key (CIK) is 1392380. EDGAR lists every GEVO filing under that number.

Ask anything about GEVO

The research agent reads GEVO's filings, financials, insider trades and 13F holders, then answers with sources.